CRISPR Gene-Editing Being Offered To British Blood Disorder Patients

Published by admin on

The first therapy that uses gene-editing is to be offered on the NHS in a “revolutionary breakthrough” for patients. From a report: It will be used as a potential cure for the blood disorder beta thalassaemia. Stem cells which make blood will be extracted, reprogrammed to correct the condition and returned to the patient’s body. It could spare them needing a blood transfusion, every three to five weeks, for life. People with beta thalassaemia struggle to produce enough haemoglobin, which is the protein in red blood cells that carries oxygen around the body. It is a genetic disease that is passed down through families and caused by defects in the body’s instructions for manufacturing haemoglobin. It can leave people severely tired, weak, and short of breath and also cuts life expectancy.

Categories: Leben (Life aka misc)Technology

Related Posts

Leben (Life aka misc) Technology

Ring Says New Encryption Limits What It Can Give Police

Ring is rolling out a new default encryption system called TAKE, or “Throw Away the Key Encryption,” that rotates video keys every five minutes and permanently deletes Ring’s copy after 24 hours. The system is Read more…

Leben (Life aka misc)

OpenAI Is Developing a ‘Persistent’ AI Agent

Wired reports that OpenAI is testing a new “Persistent mode” for Codex that would let the agent keep working until explicitly “put to sleep,” proactively creating follow-up tasks for itself across sessions and using prior Read more…

Leben (Life aka misc)

Canada Hires 48 Scholars Away From Top US Universities

Canada is recruiting 64 researchers to universities across the country, including 48 from U.S. institutions such as Harvard, Yale, and MIT. The hires are backed by more than $364 million in government funding and are Read more…